Researcher Profile

Researcher Profile

Andry Van De Louw, MD, PhD

Andry Van De Louw, MD, PhD

Associate Professor, Department of Medicine
Division of Pulmonary, Allergy and Critical Care Medicine
Scientific Program:Cancer Control

Research Interests

  • Respiratory Insufficiency
  • Mortality
  • Lung
  • Intensive Care Units
  • Critical Illness
  • Acute Myeloid Leukemia
  • Respiration
  • Hypoxia
  • Artificial Respiration
  • Oxygen
  • Hemorrhage
  • Immunocompromised Host

Recent Publications


the Nine-i Investigators 2020, 'Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura (Intensive Care Medicine, (2019), 45, 11, (1518-1539), 10.1007/s00134-019-05736-5)', Intensive Care Medicine, vol. 46, no. 3, pp. 570-571.
the Nine-i Investigators 2020, 'Diagnosis of severe respiratory infections in immunocompromised patients', Intensive Care Medicine, vol. 46, no. 2, pp. 298-314.


Van De Louw, A, Mirouse, A, Peyrony, O, Lemiale, V & Azoulay, E 2019, 'Bacterial Pneumonias in Immunocompromised Patients', Seminars in Respiratory and Critical Care Medicine, vol. 40, no. 4, pp. 498-507.
for the Efraim investigators and the Nine-I study group 2019, 'Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy', European Respiratory Journal, vol. 54, no. 1, 1802442.
On behalf of the Nine-i Investigators 2019, 'Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura', Intensive Care Medicine, vol. 45, no. 11, pp. 1518-1539.
Martin-Loeches, I, Lemiale, V, Geoghegan, P, McMahon, MA, Pickkers, P, Soares, M, Perner, A, Meyhoff, TS, Bukan, RB, Rello, J, Bauer, PR, Van De Louw, A, Taccone, FS, Salluh, J, Hemelaar, P, Schellongowski, P, Rusinova, K, Terzi, N, Mehta, S, Antonelli, M, Kouatchet, A, Klepstad, P, Valkonen, M, Landburg, PP, Barratt-Due, A, Bruneel, F, Pène, F, Metaxa, V, Moreau, AS, Souppart, V, Burghi, G, Girault, C, Silva, UVA, Montini, L, Barbier, F, Nielsen, LB, Gaborit, B, Mokart, D, Chevret, S & Azoulay, E 2019, 'Influenza and associated co-infections in critically ill immunosuppressed patients', Critical Care, vol. 23, no. 1, 152.
Domaradzki, L, Ghahramani, M, Rogers, R, Ruzieh, M, Wilson, R & de Louw, AV 2019, 'Spo2/fio2 on presentation as a predictor for early hemodynamic deterioration in intermediate risk acute pulmonary embolism', Respiratory care, vol. 64, no. 10, pp. 1279-1285.
Groupe de Recherche en Reanimation Respiratoire du patient d’Onco-Hématologie (Grrr-OH) 2019, 'Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?', Annals of Intensive Care, vol. 9, no. 1, 25.


Van de Louw, A, Lewis, AM & Yang, Z 2019, 'Autopsy findings in patients with acute myeloid leukemia and non-Hodgkin lymphoma in the modern era: a focus on lung pathology and acute respiratory failure', Annals of Hematology, vol. 98, no. 1, pp. 119-129.
Van De Louw, A, Desai, RJ, Zhu, J & Claxton, D 2018, 'Characteristics of early acute respiratory distress syndrome in newly diagnosed acute myeloid leukemia', Leukemia and Lymphoma, vol. 59, no. 10, pp. 2369-2376.
Keefer, K, Bender, R, Liao, JJ, Sivik, J & Van De Louw, A 2018, 'Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival', Annals of Hematology, vol. 97, no. 12, pp. 2373-2380.
Fitzpatrick, N, Guck, D & Van De Louw, A 2018, 'Impact of Rothman index on delay of ICU transfer for hematology and oncology patients deteriorating in wards', Critical care (London, England), vol. 22, no. 1.
Carr, ZJ, Van De Louw, A, Fehr, G, Li, JD, Kunselman, A & Ruiz-Velasco, V 2018, 'Increased whole blood FFA2/GPR43 receptor expression is associated with increased 30-day survival in patients with sepsis', BMC Research Notes, vol. 11, no. 1, 41.
Domaradzki, L, Gosala, S, Iskandarani, K & Van De Louw, A 2018, 'Is venous blood gas performed in the Emergency Department predictive of outcome during acute on chronic hypercarbic respiratory failure?', Clinical Respiratory Journal, vol. 12, no. 5, pp. 1849-1857.


for the Efraim investigators and the Nine-I study group 2017, 'Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study', Intensive Care Medicine, vol. 43, no. 12, pp. 1808-1819.
Schneider, C, Bayerl, M, Boyer, C, Desai, R, Claxton, D & Van De Louw, A 2017, 'Increased CD13 expression in acute myeloid leukemia-associated early acute hypoxic respiratory failure', American journal of respiratory and critical care medicine, vol. 196, no. 8, pp. 1077-1080.


Santos, MA, Spinazzola, J & Van de Louw, A 2016, 'A Silent Relic: Uremic Pericardial Effusion', American Journal of Medicine, vol. 129, no. 10, pp. 1057-1059.
Stefanski, M, Jamis-Dow, C, Bayerl, M, Desai, RJ, Claxton, DF & Van De Louw, A 2016, 'Chest radiographic and CT findings in hyperleukocytic acute myeloid leukemia A retrospective cohort study of 73 patients', Medicine (United States), vol. 95, no. 44, e5285.
Van de Louw, A 2017, 'Effect of leukapheresis on blood coagulation in patients with hyperleukocytic acute myeloid leukemia', Transfusion and Apheresis Science, vol. 56, no. 2, pp. 214-219.
Van de Louw, A, Desai, RJ, Schneider, CW & Claxton, DF 2016, 'Hypoxemia during extreme hyperleukocytosis: How spurious?', Respiratory care, vol. 61, no. 1, pp. 8-14.
Van De Louw, A, Schneider, CW, Desai, RJ & Claxton, D 2016, 'Initial respiratory status in hyperleukocytic acute myeloid leukemia: Prognostic significance and effect of leukapheresis', Leukemia and Lymphoma, vol. 57, no. 6, pp. 1319-1326.
Bulathsinghala, M, Keefer, K & Van De Louw, A 2016, 'Trimethoprim/Sulfamethoxazole-Induced Severe Lactic Acidosis', Medicine (United States), vol. 95, no. 17, e3478.

Clinical Trials Search

Children (age < 18 years)
Adults (age >= 18 years)